Phase I small molecule clinical trial share
Global, 2016 to 2025
62%
2025
No figure published for these periods
Phase I small molecule clinical trial share: Global, 2016 to 2025
Phase I small molecule clinical trial share: Global, 2016 to 2025. 3 observations from 2016 to 2025, ranging from 60% to 72%. Latest value 62% (2025).
%
0
20
40
60
80
2016
2018
2020
2022
2024
72%
62%
Phase I small molecule clinical trial share: Global, 2016 to 2025
Phase I small molecule clinical trial share: Global, 2016 to 2025. 3 observations from 2016 to 2025, ranging from 60% to 72%. Latest value 62% (2025).
%
0
20
40
60
80
2016
2018
2020
2022
2024
72%
62%
Phase I small molecule clinical trial share: Global, 2016 to 2025
Phase I small molecule clinical trial share: Global, 2016 to 2025. 3 observations from 2016 to 2025, ranging from 60% to 72%. Latest value 62% (2025).
%
0
20
40
60
80
2016
2018
2020
2022
2024
72%
62%
View the underlying data
Phase I small molecule clinical trial share: Global, 2016 to 2025
Period
Type
Value
2016
Actual
72%
2023
Actual
60%
2025
Actual
62%
Chart:
StatOrigin
· Source: IQVIA ·
statorigin.org
CC BY 4.0